Gallbladder cancer: Lessons from a rare tumour

被引:350
作者
Wistuba, II
Gazdar, AF [1 ]
机构
[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol & Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1038/nrc1429
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gallbladder cancer is a relatively rare form of malignancy about which our knowledge is scant. However, a unique combination of predisposing factors-including genetic predisposition, geographic distribution, female gender bias, chronic inflammation and congenital developmental abnormalities-makes this type of cancer unique and offers potential for understanding cancer pathogenesis in general. An understanding of how these risk factors contribute to the molecular basis of the disease is essential for understanding the origins of this unusual cancer.
引用
收藏
页码:695 / 706
页数:12
相关论文
共 135 条
[1]   K-ras gene mutation in gall bladder carcinomas and dysplasia [J].
Ajiki, T ;
Fujimori, T ;
Onoyama, H ;
Yamamoto, M ;
Kitazawa, S ;
Maeda, S ;
Saitoh, Y .
GUT, 1996, 38 (03) :426-429
[2]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[3]  
[Anonymous], 1992, NIH Consens Statement, V10, P1
[4]  
[Anonymous], TUMORS GALLBLADDER E
[5]   Pathogenesis of cholesterol gallstones: A parsimonious hypothesis [J].
Apstein, MD ;
Carey, MC .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (05) :343-352
[6]  
Asano T, 2002, CLIN CANCER RES, V8, P1157
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   Apolipoprotein E polymorphism and gallstones [J].
Bertomeu, A ;
Ros, E ;
Zambon, D ;
Vela, M ;
PerezAyuso, RM ;
Targarona, E ;
Trias, M ;
Sanllehy, C ;
Casals, E ;
Ribo, JM .
GASTROENTEROLOGY, 1996, 111 (06) :1603-1610
[9]  
BLACK WC, 1977, CANCER, V39, P1267, DOI 10.1002/1097-0142(197703)39:3<1267::AID-CNCR2820390338>3.0.CO
[10]  
2-0